India · Delayed Price · Currency is INR Astec LifeSciences Statistics
Total Valuation
BOM:533138 has a market cap or net worth of INR 14.19 billion. The enterprise value is 17.77 billion.
| Market Cap | 14.19B |
| Enterprise Value | 17.77B |
Important Dates
The last earnings date was Friday, January 30, 2026.
| Earnings Date | Jan 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 22.28M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +5.75% |
| Shares Change (QoQ) | +3.59% |
| Owned by Insiders (%) | 9.99% |
| Owned by Institutions (%) | 3.02% |
| Float | 5.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 53.70 |
| PS Ratio | 3.47 |
| PB Ratio | 3.43 |
| P/TBV Ratio | 3.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -19.91 |
| EV / Sales | 4.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.89 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -6.86% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 7.37M |
| Profits Per Employee | -1.61M |
| Employee Count | 555 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:533138 has paid 4.47 million in taxes.
| Income Tax | 4.47M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.57% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -28.57% |
| 50-Day Moving Average | 666.71 |
| 200-Day Moving Average | 760.40 |
| Relative Strength Index (RSI) | 51.33 |
| Average Volume (20 Days) | 8,464 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:533138 had revenue of INR 4.09 billion and -892.48 million in losses. Loss per share was -43.02.
| Revenue | 4.09B |
| Gross Profit | 1.39B |
| Operating Income | -528.89M |
| Pretax Income | -887.61M |
| Net Income | -892.48M |
| EBITDA | -43.70M |
| EBIT | -528.89M |
| Loss Per Share | -43.02 |
Balance Sheet
The company has 96.91 million in cash and 3.67 billion in debt, with a net cash position of -3.57 billion.
| Cash & Cash Equivalents | 96.91M |
| Total Debt | 3.67B |
| Net Cash | -3.57B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.14B |
| Book Value Per Share | 192.33 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 33.93%, with operating and profit margins of -12.93% and -21.82%.
| Gross Margin | 33.93% |
| Operating Margin | -12.93% |
| Pretax Margin | -21.70% |
| Profit Margin | -21.82% |
| EBITDA Margin | -1.07% |
| EBIT Margin | -12.93% |
| FCF Margin | n/a |
Dividends & Yields
BOM:533138 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.75% |
| Shareholder Yield | -5.75% |
| Earnings Yield | -6.29% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |